The role of caspase-3 mediated cleavage of VPS4A in restricting HSV-1

Active Project Grant Awarded Last action

Award ID
F30AI188981
Recipient
Awarding agency
Obligated
$191,127

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 36% complete
Place of performance
Worcester, MA 01655, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Caspases are critical initiators and executioners of programmed cell death (PCD) pathways. While these pathways function in antiviral defense, little is known about the mechanisms by which caspases and PCD pathways restrict virus replication. This is particularly true in mucosal barrier tissues, such as the oral cavity which is the entry site of numerous human pathogens including herpes simplex virus 1 (HSV-1). Recently, we found that oral epithelial keratinocytes undergo a pro-inflammatory cell death process known as pyroptosis when treated with activators of the tumor necrosis factor receptor (TNFR)-dependent extrinsic PCD pathway. In addition, activation of this extrinsic PCD pathway inhibited the replication of a HSV-1 mutant lacking the viral protein ICP6 (HSV-1 ∆ICP6), which has previously been shown to be unable to inhibit extrinsic cell death in other cell types. TNFR-mediated restriction of HSV-1 ∆ICP6 in keratinocytes was blocked with the addition of a pan-caspase inhibitor, implicating a role for caspases in inhibiting this viral mutant. Thus, oral keratinocytes represent a robust biologically relevant system to study the mechanisms by which caspases restrict virus replication. We found that several caspases, including caspase-3 and -8, were activated in normal oral keratinocytes where the TNFR-dependent extrinsic PCD pathway was activated. Further, we found that restriction of HSV-1 ∆ICP6 under these conditions occurs at a late step in the viral replication cycle (e.g., egress). Additional investigation revealed that caspase-3 activation in oral keratinocytes promotes cleavage of a pool of vacuolar protein sorting 4A (VPS4A), a component of the endosomal sorting complex required for transport (ESCRT)-III pathway. VPS4A is an AAA-atpase known to function in HSV-1 egress. Thus, the central hypothesis of this proposal is that extrinsic cell death activation results in caspase-3-mediated cleavage of VPS4A, resulting in the formation of a dominant negative protein that inhibits HSV-1 egress. We will investigate this hypothesis with two distinct aims. In aim 1, we will define the mechanism and functional consequences of VPS4A cleavage on HSV-1 replication. In aim 2, we will determine the mechanism by which TNFR-mediated extrinsic cell death activation restricts HSV-1 ∆ICP6. Completion of these aims will lead to a better understanding of the molecular mechanisms by which caspases restrict HSV-1 and fill an important GAP in the field regarding how these proteases function in antiviral defense at barrier tissues.

Transactions

Action Obligated Date
Amendment $576
Amendment $40,023
Amendment $40,023
Amendment $564
Amendment $564
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $36,459
Amendment $36,459
Original award $36,459
Show all 12

Quick answers

Who received award F30AI188981?

F30AI188981 was awarded to University Of Massachusetts Medical School by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 5, 2025.

How much is award F30AI188981 worth?

$191,127 has been obligated on F30AI188981.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login